Cargando…
Extracellular vesicles in heart failure – A study in patients with heart failure with preserved ejection fraction or heart failure with reduced ejection fraction characteristics undergoing elective coronary artery bypass grafting
AIMS: Extracellular vesicles (EVs) were investigated as potential biomarkers associated with heart failure (HF) pathophysiology in patients undergoing elective coronary artery bypass surgery characterized by HF phenotype. MATERIALS AND METHODS: Patients with preoperative proxy-diagnoses of HF types...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9622760/ https://www.ncbi.nlm.nih.gov/pubmed/36330003 http://dx.doi.org/10.3389/fcvm.2022.952974 |
_version_ | 1784821845377155072 |
---|---|
author | Matan, Dmitri Mobarrez, Fariborz Löfström, Ulrika Corbascio, Matthias Ekström, Mattias Hage, Camilla Lyngå, Patrik Persson, Bengt Eriksson, Maria Linde, Cecilia Persson, Hans Wallén, Håkan |
author_facet | Matan, Dmitri Mobarrez, Fariborz Löfström, Ulrika Corbascio, Matthias Ekström, Mattias Hage, Camilla Lyngå, Patrik Persson, Bengt Eriksson, Maria Linde, Cecilia Persson, Hans Wallén, Håkan |
author_sort | Matan, Dmitri |
collection | PubMed |
description | AIMS: Extracellular vesicles (EVs) were investigated as potential biomarkers associated with heart failure (HF) pathophysiology in patients undergoing elective coronary artery bypass surgery characterized by HF phenotype. MATERIALS AND METHODS: Patients with preoperative proxy-diagnoses of HF types i.e., preserved (HFpEF; n = 19) or reduced ejection fraction (HFrEF; n = 20) were studied and compared to patients with normal left ventricular function (n = 42). EVs in plasma samples collected from the coronary sinus, an arterial line, and from the right atrium were analyzed by flow cytometry. We studied EVs of presumed cardiomyocyte origin [EVs exposing Connexin-43 + Caveolin-3 (Con43 + Cav3) and Connexin-43 + Troponin T (Con43 + TnT)], of endothelial origin [EVs exposing VE-Cadherin (VE-Cad)] and EVs exposing inflammatory markers [myeloperoxidase (MPO) or pentraxin3 (PTX3)]. RESULTS: Median concentrations of EVs exposing Con43 + TnT and Con43 + Cav3 were approximately five to six times higher in coronary sinus compared to radial artery indicative of cardiac release. Patients with HFrEF had high trans-coronary gradients of both Con43 + TnT and Con43 + Cav3 EVs, whereas HFpEF had elevated gradients of Con43 + Cav3 EVs but lower gradients of Con43 + TnT. Coronary sinus concentrations of both Con43 + TnT and Con43 + Cav3 correlated significantly with echocardiographic and laboratory measures of HF. MPO-EV concentrations were around two times higher in the right atrium compared to the coronary sinus, and slightly higher in HFpEF than in HFrEF. EV concentrations of endothelial origin (VE-Cad) were similar in all three patient groups. CONCLUSION: Con43 + TnT and Con43 + Cav3 EVs are released over the heart indicating cardiomyocyte origin. In HFrEF the EV release profile is indicative of myocardial injury and myocardial stress with elevated trans-coronary gradients of both Con43 + TnT and Con43 + Cav3 EVs, whereas in HFpEF the profile indicates myocardial stress with less myocardial injury. |
format | Online Article Text |
id | pubmed-9622760 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-96227602022-11-02 Extracellular vesicles in heart failure – A study in patients with heart failure with preserved ejection fraction or heart failure with reduced ejection fraction characteristics undergoing elective coronary artery bypass grafting Matan, Dmitri Mobarrez, Fariborz Löfström, Ulrika Corbascio, Matthias Ekström, Mattias Hage, Camilla Lyngå, Patrik Persson, Bengt Eriksson, Maria Linde, Cecilia Persson, Hans Wallén, Håkan Front Cardiovasc Med Cardiovascular Medicine AIMS: Extracellular vesicles (EVs) were investigated as potential biomarkers associated with heart failure (HF) pathophysiology in patients undergoing elective coronary artery bypass surgery characterized by HF phenotype. MATERIALS AND METHODS: Patients with preoperative proxy-diagnoses of HF types i.e., preserved (HFpEF; n = 19) or reduced ejection fraction (HFrEF; n = 20) were studied and compared to patients with normal left ventricular function (n = 42). EVs in plasma samples collected from the coronary sinus, an arterial line, and from the right atrium were analyzed by flow cytometry. We studied EVs of presumed cardiomyocyte origin [EVs exposing Connexin-43 + Caveolin-3 (Con43 + Cav3) and Connexin-43 + Troponin T (Con43 + TnT)], of endothelial origin [EVs exposing VE-Cadherin (VE-Cad)] and EVs exposing inflammatory markers [myeloperoxidase (MPO) or pentraxin3 (PTX3)]. RESULTS: Median concentrations of EVs exposing Con43 + TnT and Con43 + Cav3 were approximately five to six times higher in coronary sinus compared to radial artery indicative of cardiac release. Patients with HFrEF had high trans-coronary gradients of both Con43 + TnT and Con43 + Cav3 EVs, whereas HFpEF had elevated gradients of Con43 + Cav3 EVs but lower gradients of Con43 + TnT. Coronary sinus concentrations of both Con43 + TnT and Con43 + Cav3 correlated significantly with echocardiographic and laboratory measures of HF. MPO-EV concentrations were around two times higher in the right atrium compared to the coronary sinus, and slightly higher in HFpEF than in HFrEF. EV concentrations of endothelial origin (VE-Cad) were similar in all three patient groups. CONCLUSION: Con43 + TnT and Con43 + Cav3 EVs are released over the heart indicating cardiomyocyte origin. In HFrEF the EV release profile is indicative of myocardial injury and myocardial stress with elevated trans-coronary gradients of both Con43 + TnT and Con43 + Cav3 EVs, whereas in HFpEF the profile indicates myocardial stress with less myocardial injury. Frontiers Media S.A. 2022-10-18 /pmc/articles/PMC9622760/ /pubmed/36330003 http://dx.doi.org/10.3389/fcvm.2022.952974 Text en Copyright © 2022 Matan, Mobarrez, Löfström, Corbascio, Ekström, Hage, Lyngå, Persson, Eriksson, Linde, Persson and Wallén. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cardiovascular Medicine Matan, Dmitri Mobarrez, Fariborz Löfström, Ulrika Corbascio, Matthias Ekström, Mattias Hage, Camilla Lyngå, Patrik Persson, Bengt Eriksson, Maria Linde, Cecilia Persson, Hans Wallén, Håkan Extracellular vesicles in heart failure – A study in patients with heart failure with preserved ejection fraction or heart failure with reduced ejection fraction characteristics undergoing elective coronary artery bypass grafting |
title | Extracellular vesicles in heart failure – A study in patients with heart failure with preserved ejection fraction or heart failure with reduced ejection fraction characteristics undergoing elective coronary artery bypass grafting |
title_full | Extracellular vesicles in heart failure – A study in patients with heart failure with preserved ejection fraction or heart failure with reduced ejection fraction characteristics undergoing elective coronary artery bypass grafting |
title_fullStr | Extracellular vesicles in heart failure – A study in patients with heart failure with preserved ejection fraction or heart failure with reduced ejection fraction characteristics undergoing elective coronary artery bypass grafting |
title_full_unstemmed | Extracellular vesicles in heart failure – A study in patients with heart failure with preserved ejection fraction or heart failure with reduced ejection fraction characteristics undergoing elective coronary artery bypass grafting |
title_short | Extracellular vesicles in heart failure – A study in patients with heart failure with preserved ejection fraction or heart failure with reduced ejection fraction characteristics undergoing elective coronary artery bypass grafting |
title_sort | extracellular vesicles in heart failure – a study in patients with heart failure with preserved ejection fraction or heart failure with reduced ejection fraction characteristics undergoing elective coronary artery bypass grafting |
topic | Cardiovascular Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9622760/ https://www.ncbi.nlm.nih.gov/pubmed/36330003 http://dx.doi.org/10.3389/fcvm.2022.952974 |
work_keys_str_mv | AT matandmitri extracellularvesiclesinheartfailureastudyinpatientswithheartfailurewithpreservedejectionfractionorheartfailurewithreducedejectionfractioncharacteristicsundergoingelectivecoronaryarterybypassgrafting AT mobarrezfariborz extracellularvesiclesinheartfailureastudyinpatientswithheartfailurewithpreservedejectionfractionorheartfailurewithreducedejectionfractioncharacteristicsundergoingelectivecoronaryarterybypassgrafting AT lofstromulrika extracellularvesiclesinheartfailureastudyinpatientswithheartfailurewithpreservedejectionfractionorheartfailurewithreducedejectionfractioncharacteristicsundergoingelectivecoronaryarterybypassgrafting AT corbasciomatthias extracellularvesiclesinheartfailureastudyinpatientswithheartfailurewithpreservedejectionfractionorheartfailurewithreducedejectionfractioncharacteristicsundergoingelectivecoronaryarterybypassgrafting AT ekstrommattias extracellularvesiclesinheartfailureastudyinpatientswithheartfailurewithpreservedejectionfractionorheartfailurewithreducedejectionfractioncharacteristicsundergoingelectivecoronaryarterybypassgrafting AT hagecamilla extracellularvesiclesinheartfailureastudyinpatientswithheartfailurewithpreservedejectionfractionorheartfailurewithreducedejectionfractioncharacteristicsundergoingelectivecoronaryarterybypassgrafting AT lyngapatrik extracellularvesiclesinheartfailureastudyinpatientswithheartfailurewithpreservedejectionfractionorheartfailurewithreducedejectionfractioncharacteristicsundergoingelectivecoronaryarterybypassgrafting AT perssonbengt extracellularvesiclesinheartfailureastudyinpatientswithheartfailurewithpreservedejectionfractionorheartfailurewithreducedejectionfractioncharacteristicsundergoingelectivecoronaryarterybypassgrafting AT erikssonmaria extracellularvesiclesinheartfailureastudyinpatientswithheartfailurewithpreservedejectionfractionorheartfailurewithreducedejectionfractioncharacteristicsundergoingelectivecoronaryarterybypassgrafting AT lindececilia extracellularvesiclesinheartfailureastudyinpatientswithheartfailurewithpreservedejectionfractionorheartfailurewithreducedejectionfractioncharacteristicsundergoingelectivecoronaryarterybypassgrafting AT perssonhans extracellularvesiclesinheartfailureastudyinpatientswithheartfailurewithpreservedejectionfractionorheartfailurewithreducedejectionfractioncharacteristicsundergoingelectivecoronaryarterybypassgrafting AT wallenhakan extracellularvesiclesinheartfailureastudyinpatientswithheartfailurewithpreservedejectionfractionorheartfailurewithreducedejectionfractioncharacteristicsundergoingelectivecoronaryarterybypassgrafting |